AXDX - Accelerate Diagnostics, Inc


0.536
-0.042   -7.761%

Share volume: 14,461
Last Updated: 04-28-2025
Measuring And Control Equipment/Lab Analytical Instruments: -0.04%

PREVIOUS CLOSE
CHG
CHG%

$0.58
-0.04
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
24%
Profitability 0%
Dept financing 25%
Liquidity 51%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
-1.62%
1 Month
-23.54%
3 Months
-59.08%
6 Months
-71.03%
1 Year
-41.91%
2 Year
-93.75%
Key data
Stock price
$0.54
P/E Ratio 
0.00
DAY RANGE
$0.54 - $0.59
EPS 
-$2.24
52 WEEK RANGE
$0.49 - $2.09
52 WEEK CHANGE
-$39.20
MARKET CAP 
30.053 M
YIELD 
N/A
SHARES OUTSTANDING 
23.679 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.52
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$21,235
AVERAGE 30 VOLUME 
$50,501
Company detail
CEO: Jack Phillips
Region: US
Website: acceleratediagnostics.com
Employees: 220
IPO year: 1996
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Accelerate Diagnostics, Inc. provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company was formerly known as Accelr8 Technology Corporation.

Recent news
loading